<html><body><h2>Case: 1287828</h2><h3> CDS Time: 1928-05-23</h3>
<patient name=1287828>
28.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">28</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">91</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">91</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">123</td><td width="200">1927-7-14</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">3</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">112</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Chloride</td><td width="200">97.0</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">42</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">80</td><td width="200">1928-5-23</td></tr>
<tr><td width="200">BNP</td><td width="200">12333.0</td><td width="200">1927-2-8</td></tr>
<tr><td width="200">Weight</td><td width="200">187</td><td width="200">1928-5-23</td></tr>
<tr><td width="200">HbA1C</td><td width="200">11</td><td width="200">1927-9-21</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">182</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">185</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">SGOT</td><td width="200">14</td><td width="200">1927-7-14</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">140</td><td width="200">1928-5-23</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1927-7-14</td></tr>
<tr><td width="200">Height</td><td width="200">64</td><td width="200">1928-5-9</td></tr>
<tr><td width="200">Potassium</td><td width="200">5</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">185</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">BUN</td><td width="200">30</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">HCT</td><td width="200">39</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">HGB</td><td width="200">14</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Sodium</td><td width="200">132</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Creatinine</td><td width="200">2.9</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">11</td><td width="200">1927-9-21</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">91.0</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">91</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">Pulse</td><td width="200">90</td><td width="200">1928-5-23</td></tr>
<tr><td width="200">PLT</td><td width="200">309</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">WBC</td><td width="200">10</td><td width="200">1928-4-10</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1928-5-23</td></tr>
<tr><td width="200">SGPT</td><td width="200">32</td><td width="200">1927-7-14</td></tr>
<tr><td width="200">Diabetes-Mellitus-Type1</td><td width="200"></td><td width="200">1928-5-23</td></tr>
<tr><td width="200">Urine_Alb/creat_Ratio_24h</td><td width="200">NOT DONE</td><td width="200">1927-9-22</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1928-1-11</td></tr>
<tr><td width="200">Urine_ALB/CREAT_RATIO_spot</td><td width="200">NOT DONE</td><td width="200">1927-9-22</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1928-5-9</td></tr>
<tr><td width="200">Diabetes with renal manifestations</td><td width="200"></td><td width="200">1928-4-10</td></tr>
<tr><td width="200">UrineAlbumin_24H</td><td width="200">>1000</td><td width="200">1927-9-22</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">UrineAlbumin_SPOT</td><td width="200">>1000</td><td width="200">1927-9-22</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1927-7-17</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1928-5-23</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1928-1-11</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) losartan(100.0) lisinopril(40.0) nitrate(60.0) hydrochlorothiazide(25.0) hydralazine(30.0) pravastatin(0.0) Insulin(4.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1927-07-17</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1928-05-09</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1928-05-23</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1928-01-11</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1928-05-23</td>
<td width="200"> Diabetes-Mellitus-Type1()</td></tr>
<tr> <td width="200"></td>
<td width="200">1928-04-10</td>
<td width="200"> Diabetes with renal manifestations()</td></tr>
<tr><td width="200">Creatinine > 1.4 and Female</td>
<td width="200"></td>
<td width="200"> Creatinine > 1.4 and Female[Sex(Female) && Creatinine(2.9/1928-4-10)]()</td></tr>
<tr><td width="200">Serum creatinine >=2</td>
<td width="200"></td>
<td width="200"> Serum creatinine >=2mg/dl[Creatinine(2.9/1928-4-10)]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1928-01-11</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1927-09-22</td>
<td width="200"> UrineAlbumin_24H()
<tr> <td width="200"></td>
<td width="200">1927-09-22</td>
<td width="200"> Urine_ALB/CREAT_RATIO_spot()
<tr> <td width="200"></td>
<td width="200">1927-09-22</td>
<td width="200"> Urine_Alb/creat_Ratio_24h()
<tr> <td width="200"></td>
<td width="200">1927-09-22</td>
<td width="200"> UrineAlbumin_SPOT()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA DM: Glycemic Control</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA DM: Glycemic Control: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(diabetes_mellitus)</i>]
</ul>
<b>Scenario choice:</b> Insulin therapy only
<p>
<b>Goal:</b> HBA1C <= target(presence of target HBA1C)
<p><b>Reached goal?</b> failed(HbA1C(11.2/1927-9-21))
<p><b>Action Choices</b>
<ul>
<li><b>DM -  Insulin only</b><br>
<ul>
<li><b>Is patient high risk? If yes, refer <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])


<li><b>Metformin contraindicated, add Glipizide <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HbA1C > Target_HbA1c</i> evaluate to <b> true</b> because <i>HbA1C(11.2/1927-9-21)</i>)])
Add Glipizide
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>GLIPIZIDE(GLIPIZIDE)<ul><li>Sulfonylurea general info when prescribing(•	Efficacy ( HbA1c) a = 1.0 - 2.0 %
•	1st generation sulfonylureas are no longer commonly used.
•	No difference in long term efficacy or failure rate has been demonstrated among the sulfonylureas.
•	The preferred agents have shorter half-lives and inactive metabolites.
•	1st generation sulfonylureas are 100% renally eliminated. Chlorpropamide and tolazamide have active metabolites.
•	Glipizide, glyburide, and glimepiride are renally eliminated by 80 - 85%, 50%, and 60% respectively. All but glipizide have active metabolites.
•	Inexpensive)<li>preference: preferred</ul></ul></body></html>